AGIO vs PVLA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PVLA Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AGIO counters with relative strength in Valuation. Fundamentally, AGIO trades at 2.5x Forward P/E with -297.7% operating margin (+330.0% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AGIO sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AGIO | PVLA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9B | $2.2B | Larger Scale | PVLA |
| Trailing P/E Ratio Valuation | 2.5x | N/M | Lower Multiple | AGIO |
| Forward P/E Ratio Valuation | 2.5x | N/M | Lower Multiple | AGIO |
| Revenue Growth (YoY) Growth | +330.0% | +0.0% | Higher Growth | AGIO |
| Operating Margin (TTM) Profitability | -297.7% | 0.0% | Higher Margin | PVLA |
| Net Profit Margin Profitability | -264.8% | 0.0% | Higher Margin | PVLA |
| Return on Equity (ROE) Capital Efficiency | -33.0% | -63.4% | Higher ROE | AGIO |
| 52-Week Range Position Momentum | 34% ($22โ$46) | 68% ($72โ$180) | Stronger Trend | PVLA |
| Beta / 30D Volatility Risk Regime | 1.12ฮฒ ยท 85% Vol | 1.66ฮฒ ยท 75% Vol | Lower Realized Risk | PVLA |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 48.2 / 100 (HOLD) | Higher Composite | AGIO |